Compare AstraZeneca plc (AZN) vs Alibaba Group (BABA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Alibaba Group — how do they compare? AstraZeneca plc trades at $158.2 (market cap $248.14B), while Alibaba Group trades at $125.7 (market cap $308.93B). The key difference: Alibaba Group is the larger of the two by market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | BABA | |
|---|---|---|
Market Cap | $248.14B | $308.93B |
Sector | Health | Consumer Cyclical |
52-Week High | $209.48 | $189.34 |
52-Week Low | $147.06 | $94.83 |
Enterprise Value | $275.41B | $303.72B |
Dividend Yield | 2.01% | 0.82% |
Volume | — | 18,069,938 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Alibaba Group
Alibaba Group Holding Limited operates as a holding company. The Company provides internet infrastructure, electronic commerce, online financial, and internet content services through its subsidiaries. Alibaba Group Holding offers its products and services worldwide.
Read more on BABA →
